In a study involving 73 patients with lung cancer, FAP expression was observed in 97.3% (71/73) of primary tumors, whereas FDG uptake on PET/CT was positive in 87.7% (64/73) (p = 0.028) [113]. This evidence concerns the gene FAP and lung cancer.